Plant derived antioxidants and antifibrotic drugs: past, present and future

@article{Ezhilarasan2014PlantDA,
  title={Plant derived antioxidants and antifibrotic drugs: past, present and future},
  author={D. Ezhilarasan and E. Sokal and S. Karthikeyan and M. Najimi and Shahalam Khan},
  journal={Journal of coastal life medicine},
  year={2014},
  volume={2},
  pages={738-745}
}
Devaraj Ezhilarasan, Etienne Sokal, Sivanesan Karthikeyan, Mustapha Najimi* Institut de Recherche Experimentale et Clinique, Laboratory of Pediatric Hepatology and Cell Therapy, Universite Catholique de Louvain, Brussels, Belgium Department of Pharmacology and Environmental Toxicology, Food and Hepatotoxicology Laboratory, Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras, Chennai, India Journal of Coastal Life Medicine 2014; 2(9): 738-745 
Hepatoprotective properties of Dandelion: recent update.
TLDR
Dandelion has been tested against various drugs and chemical induced chronic liver diseases in experimental animals and came out with promising results, and in vitro studies confirm the hepatoprotective, antioxidant and anti-inflammatory properties of dandelion. Expand
In vitro Antifungal Effects of Hesperetin and Silibinin
Background: Increasing resistance of microorganisms against available antimicrobial agents is of major concern among scientists and clinicians worldwide. To overcome the resistance and otherExpand
Silibinin Triggers the Mitochondrial Pathway of Apoptosis in Human Oral Squamous Carcinoma Cells
TLDR
The results from this study show that silibinin can be considered as a promising drug candidate for the treatment of oral squamous cell carcinoma. Expand
Cytotoxic potentials of S. cumini methanolic seed kernel extract in human hepatoma HepG2 cells
TLDR
It is demonstrated that S. cumini seed extract induced apoptosis in HepG2 cells through decrease in MMP and downregulation of HFN‐1α protein expression. Expand
Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective.
  • D. Ezhilarasan
  • Medicine
  • Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology
  • 2018
TLDR
This review summarizes the relationships between oxidative stress and different liver pathogenesis induced by drugs and xenobiotics, focusing upon different chronic liver injury induced by alcohol, antitubercular drugs and hyperactivity of antiretroviral drugs in HIV patients, viral hepatitis infection induced oxidative stress. Expand
Chemoprotective effect of omega-3 fatty acids on thioacetamide induced hepatic fibrosis in male rats
TLDR
It is suggested that omega-3 fatty acids could act against hepatic fibrosis induced by TAA due to its antioxidant properties, thus supporting its use in hepatic Fibrosis therapy. Expand
Novel lipid nanostructures for delivery of natural agents with antioxidant, antiinflammatory and antistroke potential: perspectives and outcomes
Abstract Ischemic stroke is a leading cause of mortality worldwide with limited treatment options. Since its pathophysiology involves free radical production, excitotoxicity, and stimulatedExpand
Syringic acid induces apoptosis in human oral squamous carcinoma cells through mitochondrial pathway
TLDR
Syringic acid specifically induces cell death and inhibits the proliferation in OSCC cells through intrinsic/mitochondrial apoptosis pathway, suggesting that SA may be an effective agent for the treatment of human OSCC. Expand
Nanomedicine for Hepatic Fibrosis
TLDR
Nanomedicines used as theranostic agents can provide novel therapeutic opportunities to deliver antifibrotic compounds with poor water solubility and bioavailability and highlight various nano-based HSC targets used in the treatment of liver fibrosis. Expand
Quercetin protects liver injury induced by bile duct ligation via attenuation of Rac1 and NADPH oxidase1 expression in rats.
TLDR
Quercetin demonstrated hepatoprotective activity against BDL-induced liver injury through increasing antioxidant capacity of the liver tissue, while preventing the production of Rac1, Rac1-GTP and NOX1 proteins. Expand
...
1
2
...

References

SHOWING 1-10 OF 55 REFERENCES
Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis
TLDR
Tetrandrine, an alkaloid isolated from the Chinese medicinal herb Stephania tetrandra, has been shown to exert anti‐inflammatory activity in pulmonary diseases and in vitro and in vivo effects of Tet on hepatic fibrosis were investigated. Expand
Curcumin and Diabetes: A Systematic Review
TLDR
The approaches that are currently being sought to generate a “super curcumin” through improvement of the bioavailability are mentioned to bring this promising natural product to the forefront of diabetes therapeutics. Expand
Resveratrol: from basic studies to bedside.
TLDR
Few clinical trials have yet been performed to evaluate the effectiveness of the resveratrol both in prevention and treatment of human chronic disease, and preliminary findings suggest the need for more extensive clinical investigations. Expand
PROTECTION BY AND ANTI‐OXIDANT MECHANISM OF BERBERINE AGAINST RAT LIVER FIBROSIS INDUCED BY MULTIPLE HEPATOTOXIC FACTORS
TLDR
It is suggested that berberine could be used to prevent experimental liver fibrosis through regulation of the anti‐oxidant system and lipid peroxidation. Expand
Antiproliferative mechanisms of quercetin in rat activated hepatic stellate cells.
TLDR
Investigation of the anti-proliferative effect of quercetin on activated hepatic stellate cells (aHSCs), the central role of hepatofibrosis, and the proteins involved in growth inhibition by a 2D gel electrophoretic analysis revealed that proper consumption of quERCetin could be beneficial to control the progression of hept ofibrosis. Expand
Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells.
TLDR
Molecular insights into the potential therapeutic action of Silybin in chronic liver disease are provided and this action seems to be mostly related to a marked inhibition of the production of pro-inflammatory cytokines, a clear anti-oxidant effect and a reduction of the direct and indirect pro-fibrogenic potential of HSC. Expand
Strong antiproliferative effects of baicalein in cultured rat hepatic stellate cells.
TLDR
The strong antiproliferative effect of baicalein in hepatic stellate cells is demonstrated, showing the possibility of baicalsein as an antifibrogenetic drug for hepatic fibrosis. Expand
Antifibrotic effects of chronic baicalein administration in a CCl4 liver fibrosis model in rats.
TLDR
It is suggested that chronic baicalein administration inhibits stellate cell activation and proliferation by the down-regulation of PDGF-beta receptor and prevents the development of CCl(4) induced liver fibrosis in rats. Expand
PREVENTION OF CCL4‐INDUCED LIVER CIRRHOSIS BY SILYMARIN
Summary— The efficacy of silymarin treatment in preventing biochemical and histological alterations in CCl4‐induced liver cirrhosis in rats was studied. Four groups of rats were treated with: (1)Expand
Effect of Antioxidant Treatment on Fibrogenesis in Rats with Carbon Tetrachloride-Induced Cirrhosis
TLDR
The use of quercetin might be promising as an antioxidant therapy in liver fibrosis as confirmed by the decrease of substances reacting to thiobarbituric acid (TBARS), the increased activity of antioxidant enzymes, and the reduced glutathione ratio and glutATHione disulfide (GSH/GSSG). Expand
...
1
2
3
4
5
...